Breast Cancer

We build your team of breast cancer experts based on your needs, providing personalized, compassionate care.

First, we identify the specific type of breast cancer using microscopic analysis, genetic testing, and imaging. Then, we create an individualized treatment plan for you. At the Breast Cancer Center, part of NYU Langone’s Perlmutter Cancer Center, our experts provide the most advanced treatments, such as breast-conserving surgery and targeted drugs, and our researchers evaluate promising new treatments for breast cancer in clinical trials.

We offer comprehensive support services including fertility preservation counseling, psychological support, and integrative therapies.

We counsel women who are at high risk for developing breast cancer, and our experts frequently provide second opinions.

Clinical Trials and Research Studies

Phase 3

The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD) A Double-Blinded Phase III Randomized Trial of T-DM1 Compared with T-DM1 and Tucatinib

Learn More

Phase 1

An Open-label Multicenter Dose Escalation Phase 1b Study to Assess the Safety and Pharmacokinetics of Subcutaneous Delivery of Amivantamab a Human Bispecific EGFR and cMet Antibody for the Treatment of Subjects with Advanced Non-Small Cell Lung Cancer

Learn More

Phase 2

A Global Phase 2 Study of ARX788 in HER2-positiveMetastatic Breast Cancer Patients Whose Disease is Resistant or Refractory to T-DM1 and/or T-DXd and/or Tucatinib-containing Regimens

Learn More

Phase 5

A Phase 1 Open Label Dose-Escalation and Expansion Study of Oral ORIN1001 with and without Chemotherapy in the Treatment of Subjects with Solid Tumors

Learn More